Exploring the impact of auricular acupressure and nutritional assistance, enhanced with ferulic acid supplementation, on pediatric cough variant asthma: An observational study.

The treatment group showed significantly greater reductions in Cough Severity Index (CSI) scores at all follow-up time points compared to controls.

• CSI reductions were measured at 3, 6, and 12 months post-treatment initiation
• Differences in CSI scores between treatment and control groups were statistically significant (P < .05) at all three time points
• The treatment group received auricular acupressure combined with ferulic acid supplementation
• The control group received standard care only

Improvements in lung function indices FEV1 and FVC were more pronounced in the treatment group than in the control group.

• Differences in FEV1 and FVC improvements between groups were statistically significant (P < .01)
• The more stringent significance threshold (P < .01) suggests a stronger effect on pulmonary function than on symptom scores
• Lung function was assessed as a secondary outcome alongside quality-of-life measures

Quality-of-life scores as measured by the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) increased significantly among patients receiving the integrative therapy.

• PAQLQ was used as a secondary outcome measure
• Quality-of-life improvements were described as significant in the treatment group
• The study included 236 children diagnosed with CVA treated between April 2022 and November 2024
• Patients were treated at the Department of Traditional Chinese Medicine, Gongli Hospital of Shanghai Pudong

The study was a retrospective observational study of 236 pediatric patients with cough variant asthma categorized into treatment and control groups based on treatment received.

• Medical records of 236 children diagnosed with CVA were reviewed
• Patients were categorized into a treatment group (auricular acupressure plus ferulic acid supplementation) or a control group (standard care only) based on treatment received, not randomization
• The study covered the period April 2022 to November 2024
• Primary outcome was change in Cough Severity Index (CSI); secondary outcomes included PAQLQ scores and pulmonary function tests

The authors concluded that the integrative approach warrants further prospective and randomized investigations to validate its clinical value.

• The findings are limited by the retrospective, non-randomized observational design
• The authors explicitly acknowledged the need for prospective and randomized studies
• Cough variant asthma is described as a common cause of chronic cough in children that significantly affects health and quality of life
• The study was framed as exploring 'potential complementary treatment strategies'